Developing two businesses that supply products of high quality and originality
Pharmaceuticals
Revenue¥ 125,105 billion (as of March 31, 2024)
In the Pharmaceuticals business, since Nippon Shinyaku announced its intention in 2007 to “launch at least one product each year,” it has been consistently achieving this goal by not only undertaking in-house drug discovery based on the R&D capabilities built up since the founding of the company in 1919 but also introducing in-licensed products and undertaking PLCM＊. The Sales and Marketing Division aims to deliver medicines required by patients as quickly as possible by sharing high-quality information and building a system to quickly respond to the needs of medical professionals.
The Company also proactively takes on challenges in fields that other companies avoid and moves forward with research and development of original treatments to create distinctive pharmaceuticals required by patients suffering from disease and their families and to be a company that is trusted by society.
＊ PLCM (product life-cycle management) is a way to increase the value of products through efforts such as pursuing new efficiency and adding new dosage forms for products on the market and drug candidates still in development.
Functional Food
Revenue¥ 23,150 billion (as of March 31, 2024)
In the Functional Food business, Nippon Shinyaku seeks to leverage its advanced technical expertise as a maker of pharmaceuticals to supply high-value-added products that meet market needs, focusing on supplements in addition to its bulk materials businesses in health food ingredients, preservatives, and protein preparations. The Company will “Help People Lead Healthier, Happier Lives,” through approaches other than pharmaceuticals, including by taking on the challenge of dealing with social issues, such as food loss, and contributing to better health through health food ingredients and supplements. It will show meaningful existence and contribute to the extension of healthy life expectancy for people by reinforcing its R&D capabilities and continually bringing to market highly original new products.